MapLight Therapeutics, Inc. MPLT
6.63 USD -0.18 (-2.64%)
Nov 4, 2026, 11:51 AM EST
6.50 Day range 7.14
6.63 52-week range 39.80
- YTD
- -62.27%
- 1 year
- -59.17%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 41.50 +525.9% upside
Now 6.63
- Target (low)
- 30.00
- Target (mean)
- 41.50
- Target (high)
- 60.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy2
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 12
- 2 months ago 11
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.40 | -1.45 – -1.32 | 0.00 | 0.0% | 0 | 0.0% | 7 |
| Next quarter | -1.26 | -1.35 – -1.06 | 0.00 | 0.0% | 0 | 0.0% | 7 |
| Current year | -5.14 | -5.41 – -4.65 | -18.56 | +72.3% | 0 | 0.0% | 7 |
| Next year | -3.74 | -5.30 – -0.10 | -5.14 | +27.3% | 20.00M | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 10, 2026 | Needham | Maintained | Buy | Buy |
| Jun 25, 2026 | Raymond James | Initiated | — | Strong Buy |
| Jun 23, 2026 | Craig-Hallum | Maintained | Buy | Buy |
| Jun 22, 2026 | Needham | Maintained | Buy | Buy |
| Jun 2, 2026 | Stifel | Maintained | Buy | Buy |
| May 28, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 27, 2026 | UBS | Initiated | — | Buy |
| May 21, 2026 | Craig-Hallum | Initiated | — | Buy |
| May 4, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 8, 2026 | Needham | Initiated | — | Buy |
| Apr 7, 2026 | TD Cowen | Initiated | — | Buy |
| Mar 19, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Nov 21, 2025 | Jefferies | Initiated | — | Buy |
| Nov 21, 2025 | Leerink Partners | Initiated | — | Outperform |
| Nov 21, 2025 | Stifel | Initiated | — | Buy |
| Nov 21, 2025 | Morgan Stanley | Initiated | — | Overweight |